share_log

Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know

Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know

來自IDEAYA生物科學分析師評級的關鍵見解:你需要知道的
Benzinga ·  01/11 01:01
In the latest quarter, 7 analysts provided ratings for IDEAYA Biosciences (NASDAQ:IDYA), showcasing a mix of bullish and bearish perspectives.
在最近一個季度中,7位分析師爲IDEAYA Biosciences(納斯達克股票代碼:IDYA)提供了評級,顯示了看漲和看跌的觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的評級,展示了過去30天情緒的演變,並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $40.86, a high estimate of $44.00, and a low estimate of $36.00. Surpassing the previous average price target of $37.75, the current average has increased by 8.24%.
分析師通過對12個月目標股價的評估提供了更深入的見解,顯示平均目標價爲40.86美元,最高估計爲44.00美元,低估值爲36.00美元。超過了之前的平均目標股價37.75美元,目前的平均價格上漲了8.24%。
Decoding Analyst Ratings: A Detailed Look
解碼分析師評級:詳細介紹
An in-depth analysis of recent analyst actions unveils how...
對分析師近期行爲的深...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論